Protection by a Commercial Arkansas-Type Infectious Bronchitis Virus Vaccine against a Field Isolate of the Same Serotype

1997 ◽  
Vol 41 (4) ◽  
pp. 964 ◽  
Author(s):  
Jean E. Sander ◽  
Mark W. Jackwood ◽  
George N. Rowland
Keyword(s):  
Virus Vaccine ◽  
Infectious Bronchitis Virus ◽  
Field Isolate ◽  
Infectious Bronchitis

scholarly journals Characterization of a novel live attenuated infectious bronchitis virus vaccine candidate derived from a Korean nephropathogenic strain

Vaccine ◽  
2010 ◽  
Vol 28 (16) ◽  
pp. 2887-2894 ◽  
Author(s):  
Hyun Jeong Lee ◽  
Ha Na Youn ◽  
Ji Sun Kwon ◽  
Youn Jeong Lee ◽  
Jae Hong Kim ◽  
...  
Keyword(s):  
Virus Vaccine ◽  
Infectious Bronchitis Virus ◽  
Vaccine Candidate ◽  
Infectious Bronchitis

scholarly journals Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine

Vaccine ◽  
2018 ◽  
Vol 36 (29) ◽  
pp. 4245-4254 ◽  
Author(s):  
Yun Zhang ◽  
Songjian Huang ◽  
Yuyao Zeng ◽  
Chunyi Xue ◽  
Yongchang Cao
Keyword(s):  
Virus Vaccine ◽  
Infectious Bronchitis Virus ◽  
Rapid Development ◽  
Infectious Bronchitis

Isolation of 4/91 Type of Infectious Bronchitis Virus as a New Variant in Japan and Efficacy of Vaccination Against 4/91 Type Field Isolate

2008 ◽  
Vol 52 (4) ◽  
pp. 618-622 ◽  
Author(s):  
Yohko Shimazaki ◽  
Takashi Horiuchi ◽  
Makiko Harada ◽  
Chieko Tanimura ◽  
Yoshihisa Seki ◽  
...  
Keyword(s):  
Infectious Bronchitis Virus ◽  
Field Isolate ◽  
Infectious Bronchitis ◽  
New Variant

scholarly journals Inactivated infectious bronchitis virus vaccine encapsulated in chitosan nanoparticles induces mucosal immune responses and effective protection against challenge

Vaccine ◽  
2018 ◽  
Vol 36 (19) ◽  
pp. 2630-2636 ◽  
Author(s):  
Priscila Diniz Lopes ◽  
Cintia Hiromi Okino ◽  
Filipe Santos Fernando ◽  
Caren Pavani ◽  
Viviane Mariguela Casagrande ◽  
...  
Keyword(s):  
Immune Responses ◽  
Virus Vaccine ◽  
Infectious Bronchitis Virus ◽  
Chitosan Nanoparticles ◽  
Effective Protection ◽  
Infectious Bronchitis ◽  
Mucosal Immune Responses

Differentiation of infectious bronchitis virus vaccine strains Ma5 and 4/91 by TaqMan real-time PCR

2017 ◽  
Vol 20 (3) ◽  
pp. 599-601 ◽  
Author(s):  
T. Stenzel ◽  
D. Dziewulska ◽  
M. Śmiałek ◽  
B. Tykałowski ◽  
J. Kowalczyk ◽  
...  
Keyword(s):  
Real Time ◽  
Virus Vaccine ◽  
Infectious Bronchitis Virus ◽  
Real Time Pcr ◽  
Cross Reactivity ◽  
Specific Primers ◽  
Assay Sensitivity ◽  
Infectious Bronchitis ◽  
Molecular Assays ◽  
Rapid Molecular Assays

Abstract The aim of this study was to develop rapid molecular assays for differentiating vaccine strains Ma5 and 4/91 of the infectious bronchitis virus (IBV). Specific primers and probes for S1 and N genes were designed based on the nucleotide sequences of both vaccine strains. Cross-reactivity was not observed. Assay sensitivity was 2.373 × 103 copies of the Ma5 strain, and 3.852 x 103 copies of the 4/91 strain. Samples belonging to a known genotype demonstrated that the designed assays supported rapid and sensitive detection of Ma5 and 4/91 vaccine strains of IBV.

scholarly journals Live attenuated nephropathogenic infectious bronchitis virus vaccine provides broad cross protection against new variant strains

2012 ◽  
Vol 91 (1) ◽  
pp. 89-94 ◽  
Author(s):  
T.-H. Lim ◽  
M.-S. Kim ◽  
J.-H. Jang ◽  
D.-H. Lee ◽  
J.-K. Park ◽  
...  
Keyword(s):  
Virus Vaccine ◽  
Infectious Bronchitis Virus ◽  
Cross Protection ◽  
Infectious Bronchitis ◽  
New Variant
Sign in / Sign up

Export Citation Format

Share Document